title: Phase II trial of 13-cis-retinoic acid plus interferon alpha in non-small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group.
authors.affiliation: Division of Medical Oncology, Hamilton Regional Cancer Centre, ON, Canada.
authors.forename: A
authors.initials: A
authors.lastname: Arnold
authors.forename: J
authors.initials: J
authors.lastname: Ayoub
authors.forename: L
authors.initials: L
authors.lastname: Douglas
authors.forename: P
authors.initials: P
authors.lastname: Hoogendoorn
authors.forename: L
authors.initials: L
authors.lastname: Skingley
authors.forename: K
authors.initials: K
authors.lastname: Gelmon
authors.forename: V
authors.initials: V
authors.lastname: Hirsh
authors.forename: E
authors.initials: E
authors.lastname: Eisenhauer
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000556:secondary; D005260:Female; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage; D015474:Isotretinoin / Q000008:administration & dosage; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome
chemical_list: D016898:Interferon-alpha; D015474:Isotretinoin